Montgomery Martin
About
In The Last Decade
Montgomery Martin
12 papers receiving 288 citations
Peers
Comparison fields: 5 of 45
- Pulmonary and Respiratory Medicine 139
- Radiation 84
- Epidemiology 84
- Neurology 83
- Radiology, Nuclear Medicine and Imaging 79
Countries citing papers authored by Montgomery Martin
This map shows the geographic impact of Montgomery Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Montgomery Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Montgomery Martin more than expected).
Fields of papers citing papers by Montgomery Martin
This network shows the impact of papers produced by Montgomery Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Montgomery Martin. The network helps show where Montgomery Martin may publish in the future.
Co-authorship network of co-authors of Montgomery Martin
This figure shows the co-authorship network connecting the top 25 collaborators of Montgomery Martin. A scholar is included among the top collaborators of Montgomery Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Montgomery Martin. Montgomery Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 18 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | FDG PET early metabolic response to the PARP inhibitor olaparib (AZD2281) in BRCA-deficient or recurrent high-grade ovarian carcinoma and BRCA-deficient or triple-negative breast cancer | 1 |
| 8 | 17 | |
| 9 | 3 | |
| 10 | 64 | |
| 11 | 61 | |
| 12 | 112 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.